Summary
Summary
- 92% of patients with acute hepatic porphyria (AHP) present with severe abdominal pain during attacks.1
- Patients are often referred to gastroenterologists with abdominal pain of unknown origin, many of whom have been misdiagnosed for many years.2-4
- A differential diagnosis of AHP should be considered for these patients who are frequently referred with unexplained, chronic, or recurring bouts of abdominal pain.5
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Herbert L. Bonkovsky, MD, is a Professor of Internal Medicine and Director of Liver Services/Chief, Laboratory for Liver and Metabolic Disorders at Wake Forest University School of Medicine, Winston-Salem, North Carolina. Dr Bonkovsky is known nationally and internationally as a leading clinical gastroenterologist and hepatologist, teacher, mentor, and clinical investigator.
He is a valedictory graduate of Earlham College in Richmond, IN and Case Western Reserve University School of Medicine in Cleveland, OH. His post-graduate training was at Duke University, Case Western Reserve University School of Medicine, the U.S. National Institutes of Health, Dartmouth Medical School, and Yale University.
Dr Bonkovsky formerly served as Director of the Division of Digestive Disease and Nutrition at the University of Massachusetts Medical School and as Director of the Office of Clinical Research and the General Clinical Research Center and Director of the Liver- Biliary-Pancreatic Center at the University of Connecticut Health Center. Dr Bonkovsky has continued to maintain an active clinical practice focused on liver disorders and metabolic disorders, especially disorders of iron, porphyrin, and heme metabolism.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
This program was sponsored and funded by Alnylam Pharmaceuticals, Inc, based on an interview with Herbert L. Bonkovsky, MD, FACP, FACG, FAGA, FAASLD. Dr Bonkovsky received a fee for participation in this program. AS1-CEMEA-00184 . Date of preparation: February 2021.
For Healthcare Professionals Only.